Cardiovascular Risks Associated with Bicalutamide and Androgen Deprivation Therapy

Cardiac Safety Signals from Combination Therapy

Elevated Mortality in Patients with Pre‑Existing Cardiac Disease

Baseline Cardiac Assessment Recommendations

Need for Cardiology Co‑Management

Duration‑Related Cardiovascular Risks of ADT

Comparative Cardiovascular Profile of Alternative Anti‑androgens

Uncertainty Regarding Bicalutamide’s Independent Contribution